Rite Aid has chosen a former insurance executive to replace long-time CEO John Standley to try to right the struggling drugstore chain.
The company said Monday that Heyward Donigan will take over immediately for Standley, who's been CEO since 2010.
The 58-year-old Donigan is a former executive with Premera Blue Cross. She most recently served as CEO of Sapphire Digital, which runs a technology platform that helps people shop for care.
Donigan takes over a company that runs nearly 2,500 drugstores and lost $99.7 million in its first quarter. Rite Aid's board approved a reverse stock split this year to lift plummeting share prices and keep them on the New York Stock Exchange.
Shares of Rite Aid Corp., based in Camp Hill, Pennsylvania, rose almost 3% at the opening bell.
Before you consider Rite Aid, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Rite Aid wasn't on the list.
While Rite Aid currently has a "hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
